Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours ยท Estimated delivery Aug 14 - Aug 19
Latest Batch Verified Lot BSL022026 Tested Feb 18, 2026 HPLC purity, identity (MS), endotoxin, heavy metals all specs passed
Repeated injections into the same spot cause scar tissue and lipohypertrophy, both of which reduce B12 absorption over time
De Luca, A., Maiello, M
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
US$ 22.56
US$ 21.54
US$ 21.08
